Scaling up the human papillomavirus (HPV) vaccine could eradicate cervical cancer in high-income countries within 30 years, with most other countries following by the end of the century, according to new research.
In 2018, there were 570,000 new cases of cervical cancer, which represented 6.6% of all female cancers. The World Health Organization (WHO) stated that around 90% of these deaths occurred in low- and middle-income countries.